Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index; 7 of the 22 sources its claims cite were checked for support.
Abstract
OBJECTIVE—A lower in vivo mitochondrial function has been reported in both type 2 diabetic patients and first-degree relatives of type 2 diabetic patients. The nature of this reduction is unknown. Here, we tested the hypothesis that a lower intrinsic mitochondrial respiratory capacity may underlie lower in vivo mitochondrial function observed in diabetic patients. RESEARCH DESIGN AND METHODS—Ten overweight diabetic patients, 12 first-degree relatives, and 16 control subjects, all men, matched for age and BMI, participated in this study. Insulin sensitivity was measured with a hyperinsulinemic-euglycemic clamp. Ex vivo intrinsic mitochondrial respiratory capacity was determined in permeabilized skinned muscle fibers using high-resolution respirometry and normalized for mitochondrial content. In vivo mitochondrial function was determined by measuring phosphocreatine recovery half-time after exercise using 31P-magnetic resonance spectroscopy. RESULTS—Insulin-stimulated glucose disposal was lower in diabetic patients compared with control subjects (11.2 ± 2.8 vs. 28.9 ± 3.7 μmol · kg−1 fat-free mass · min−1, respectively; P = 0.003), with intermediate values for first-degree relatives (22.1 ± 3.4 μmol · kg−1 fat-free mass · min−1). In vivo mitochondrial function was 25% lower in diabetic patients (P = 0.034) and 23% lower in first-degree relatives, but the latter did not reach statistical significance (P = 0.08). Interestingly, ADP-stimulated basal respiration was 35% lower in diabetic patients (P = 0.031), and fluoro-carbonyl cyanide phenylhydrazone–driven maximal mitochondrial respiratory capacity was 31% lower in diabetic patients (P = 0.05) compared with control subjects with intermediate values for first-degree relatives. CONCLUSIONS—A reduced basal ADP-stimulated and maximal mitochondrial respiratory capacity underlies the reduction in in vivo mitochondrial function, independent of mitochondrial content. A reduced capacity at both the level of the electron transport chain and phosphorylation system underlies this impaired mitochondrial capacity.
Overview
CoChat Summary
TL;DR
In male type 2 diabetic patients, in vivo mitochondrial function (phosphocreatine recovery half-time) was 25% lower than in age- and BMI-matched control subjects, and ex vivo ADP-stimulated state 3 respiration was 35% lower after normalization for mitochondrial content. These intrinsic defects involved both electron transport chain and phosphorylation system capacity, with intermediate or tendency values in first-degree relatives.
Key findings
- Insulin-stimulated glucose disposal was lower in diabetic patients than control subjects (11.2 ± 2.8 vs. 28.9 ± 3.7 μmol · kg−1 fat-free mass · min−1, P = 0.003), with intermediate values in first-degree relatives (22.1 ± 3.4 μmol · kg−1 fat-free mass · min−1).
- In vivo mitochondrial function was 25% lower in diabetic patients (PCr recovery half-time 23.8 ± 2.0 vs. 17.9 ± 1.2 s, P = 0.034); first-degree relatives had a 23% longer PCr-t1/2 (23.1 ± 2.0 s) but this did not reach significance (P = 0.08).
- After normalization for mitochondrial content, ADP-stimulated state 3 respiration was 35% lower in diabetic patients (P = 0.031), and FCCP-driven maximal respiratory capacity was 31% lower (P = 0.05); state 4 respiration did not differ between groups.
- Mitochondrial density (mtDNA copy number and citrate synthase activity) did not differ between groups, indicating that the lower respiration was intrinsic rather than due to reduced mitochondrial content.
Methods
- Cross-sectional study of 10 male type 2 diabetic patients, 12 male first-degree relatives, and 16 male control subjects matched for age and BMI; insulin sensitivity was measured with a 3-h hyperinsulinemic-euglycemic clamp using [6,6-2H2]glucose.
- In vivo mitochondrial function was determined by 31P-MRS as phosphocreatine recovery half-time after knee-extension exercise; ex vivo mitochondrial respiration was measured by high-resolution respirometry in permeabilized skinned muscle fibers, with normalization to mtDNA copy number or citrate synthase activity.
- Group differences were analyzed by one-way ANOVA with Tukey’s post hoc correction; Spearman correlations were computed; significance was set at P < 0.05.
Limitations
- Stated: physical activity was assessed by questionnaire and maximal aerobic capacity and was similar between groups, but the paper notes the reason for lower intrinsic mitochondrial capacity is unknown and may involve ultrastructural mitochondrial changes; whether mitochondrial size determines overall capacity needs further investigation.
- Evident: all participants were men, group sizes were modest (10 diabetic patients, 12 first-degree relatives, 16 control subjects), and first-degree relative differences were not statistically significant (e.g., PCr-t1/2 P = 0.08), limiting power and generalizability.
- Evident: the cross-sectional design cannot establish whether intrinsic mitochondrial defects precede or are a consequence of type 2 diabetes or insulin resistance.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
5 Valid · 0 Not valid · 10 Not checked · 62 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In contrast, using an alternative method to measure in vivo mitochondrial function with 31P-MRS, we recently showed an ∼40% lower mitochondrial function in type 2 diabetic patients compared with age- and BMI-matched control subjects (8).”
§ Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients > Abstract
What the sources say
- Partly supportedcites [8] Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Jeneson JA, Backes WH, van Echteld CJ, van Engelshoven JM, Mensink M, Schrauwen P: Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 50:113–120,2007 sourceExperimental — accuracy not yet measured
The In vivo mitochondrial function section reports a 45% longer PCr recovery half-time in patients with type 2 diabetes, indicating impaired mitochondrial function; the Discussion describes a 45% drop. However, the Subject characteristics section says the groups were BMI-matched but differed significantly in age (61.8 versus 56.1 years), so they were not age-matched. Page numbers are unavailable in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“So far, three studies have reported mitochondrial function ex vivo in a diabetic population (13–15), with conflicting results.”
§ Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients > Abstract
What the sources say
- Supportedcites [13] Mogensen M, Sahlin K, Fernstrom M, Glintborg D, Vind BF, Beck-Nielsen H, Hojlund K: Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 56:1592–1599,2007 source
The Discussion (page not provided) reports measurements of respiration in isolated skeletal-muscle mitochondria from patients with type 2 diabetes and nondiabetic controls. This identifies the paper as an ex vivo mitochondrial-function study in a diabetic population, the role for which it is cited among the three studies. (LLM, conf=0.91)
- Supportedcites [14] Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsoe R, Dela F: Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 50:790–796,2007 source
The Subjects and methods passage identifies this paper as a study measuring mitochondrial respiration in permeabilised skeletal muscle fibres from men with type 2 diabetes, supporting its inclusion among ex vivo studies. The Discussion reports normal mitochondrial function after adjustment for mitochondrial content and says this does not support other investigations reporting dysfunction, consistent with conflicting results. (LLM, conf=0.92)
- Supportedcites [15] Stump CS, Short KR, Bigelow ML, Schimke JM, Nair KS: Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci U S A 100:7996–8001,2003 source
This paper is one of the studies the citation group identifies. Materials and Methods describes measuring ATP production in mitochondria separated from muscle biopsies, including biopsies from people with type 2 diabetes; Results reports the diabetic group’s findings. The statement that results conflict concerns the three studies collectively, not a finding attributed to this paper alone. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“We confirmed our previous finding (8) of compromised in vivo mitochondrial function, determined as the rate of PCr recovery after exercise in type 2 diabetic patients compared with age- and BMI-matched control subjects”
§ Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients > DISCUSSION
What the sources say
- Partly supportedcites [8] Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Jeneson JA, Backes WH, van Echteld CJ, van Engelshoven JM, Mensink M, Schrauwen P: Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 50:113–120,2007 sourceExperimental — accuracy not yet measured
The core of the claim is confirmed: 'In vivo mitochondrial function' (Results) reports mean PCr recovery half-time 45% longer in the type 2 diabetes group (27.3±3.5 vs 18.7±0.9 s, p<0.05), 'indicating impaired in vivo mitochondrial function', and the Abstract and Discussion repeat this. However, the qualifier 'age- and BMI-matched' is not what this study did: 'Subject characteristics' states the groups were 'carefully matched for BMI (29.4±1.0 and 29.3±0.9 kg/m2)' but age was 61.8±1.3 vs 56.1±2.3 years (p<0.05), and the Discussion explicitly addresses this 6-year age difference as a possible contributor. So the age-matching description of the comparison is unsupported (indeed contrary to the source's own data). (LLM, conf=0.82)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Mitochondrial density measured as mtDNA copy number and as citrate synthase activity was not different between groups (mtDNA copy number 5,813 ± 388, 5,573 ± 716, and 5,621 ± 430 arbitrary units; citrate synthase activity 92 ± 4.8, 103 ± 13.0, and 89 ± 7.4 μmol · g−1 protein · min−1, respectively, in diabetic patients, first-degree relatives, and control subjects; NS).”
§ Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients > RESULTS > Mitochondrial density.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In vivo mitochondrial function was 25% lower in diabetic patients (P = 0.034) and 23% lower in first-degree relatives, but the latter did not reach statistical significance (P = 0.08).”
- Also stated in: § In vivo mitochondrial function. · hedged
“Mean PCr recovery half-time (PCr-t1/2) was prolonged by 25% in diabetic patients compared with control subjects (23.8 ± 2.0 vs. 17.9 ± 1.2 s, respectively; P = 0.034) (Fig. 2), indicating impaired in vivo mitochondrial function in diabetic patients.”
§ Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § In vivo mitochondrial function. · hedged
40 more claims
Create a free account to see all 77 claims and to verify the 15 references still open.
- It may state two separate claims as one. 25
- Probably not a substantial claim. 9
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Although the existence of mitochondrial abnormalities in patients with type 2 diabetes has been extensively reported during the last decade (1–5), there is no evidence that a reduced mitochondrial function is a primary factor in the pathophysiology of this disease.”
From Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance (2010) · cites this paper as [4]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“a similar reduction in intrinsic mitochondrial capacity, without differences in mitochondrial content, was recently reported by us in type 2 diabetic patients and first degree relatives when compared with BMI- and age-matched obese control subjects (4).”
From Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance (2010) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it has generally been assumed that a reduction in muscle mitochondrial function will result in reductions in whole-body fat oxidative capacity (3–5,42,43).”
From Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance (2010) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, decreased mitochondrial respiration was found in first-degree relatives of individuals with T2DM139.”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most importantly, a decrease in mitochondrial respiration was reported in the first-degree relatives of individual with T2DM (Phielix et al., 2008) indicating that mitochondrial dysfunction may precede the onset of full blown T2DM.”
From Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular Mechanisms to the Impact of Diet (2019) · cites this paper as Phielix et al., 2008
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 2×
“To measure peripheral insulin sensitivity, a 3-h hyperinsulinemic-euglycemic (40 mU m 2 min (1)) clamp, according to DeFronzo (18), was performed after an overnight fast with primed infusion of [6,6-(2)H2]glucose (0.”
MethodInfluentialCellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Calculation of substrate oxidation rates in vivo from gaseous exchange.
Frayn, K. N. (1983) · Journal of Applied Physiology · doi:10.1152/jappl.1983.55.2.628 · Cited by 2,365 · cited 1×
“Fat and carbohydrate oxidation were calculated using stoichiometric equations according to Frayn (25) with the assumption that protein oxidation was negligible.”
MethodDysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321 · cited 1×
“In that respect, smaller mitochondria have been reported for type 2 diabetic patients (1), and mitochondrial size was related to insulin sensitivity (1,26).”
BackgroundImpaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · cited 2×
“Lower basal ATP synthesis rate in insulin-resistant first-degree relatives has been reported previously (6) when compared with insulin-sensitive healthy control subjects.”
ResultMitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · cited 2×
“Using this methodology, they reported that resting muscular ATP synthesis was decreased by 40% in insulinresistant elderly compared with insulin-sensitive young control subjects (3).”
BackgroundPatti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
The Gross Composition of the Body
SIRI, W. E. (1956) · Advances in Biological and Medical Physics · doi:10.1016/b978-1-4832-3110-5.50011-x · Cited by 1,765 · cited 1×
“determined using hydrostatic weighing (17).”
Diet, muscle glycogen and physical performance.
Bergström, J., Hermansen, L., Hultman, E., & Saltin, B. (1967) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1967.tb03720.x · Cited by 1,740
Cited by
Items 101–200 of 358
Mitochondrial involvement in skeletal muscle insulin resistance: A case of imbalanced bioenergetics
Affourtit, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.07.008 · Cited by 67
Rabøl, R., Larsen, S., Højberg, P. M. V., Almdal, T., Boushel, R., Haugaard, S. B., Andersen, J. L., Madsbad, S., & Dela, F. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1844 · Cited by 67
“ported (6, 7), but controversy exists in this area (4, 8).”
BackgroundEffect of hyperglycemia on mitochondrial respiration in type 2 diabetes.
Rabøl, R., Højberg, P. M. V., Almdal, T., Boushel, R., Haugaard, S. B., Madsbad, S., & Dela, F. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1475 · Cited by 66
“is due to intrinsic defects in the mitochondria (9, 10) or to a”
BackgroundGiebelstein, J., Poschmann, G., Højlund, K., Schechinger, W., Dietrich, J. W., Levin, K., Beck‐Nielsen, H., Podwojski, K., Stühler, K., Meyer, H. E., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2456-x · Cited by 77
“Although the mitochondrial content and dysfunction in insulin-resistant states has been studied extensively [2–12, 32, 35, 36], few data exist about the potential”
BackgroundDeLany, J. P., Dubé, J. J., Standley, R. A., Distefano, G., Goodpaster, B. H., Stefanovic-Racic, M., Coen, P. M., & Toledo, F. G. S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2512 · Cited by 66
“These findings are similar to observations in individuals with type 2 diabetes and can be ascribed to an involvement of the electron transport chain and oxidative phosphorylation system (27).”
ResultYap, K. H., Gan, S. Y., Candasamy, M., Tan, S. C., Md, S., Majeed, A. B. A., & Bhattamisra, S. K. (2020) · Biomolecules · doi:10.3390/biom10101360 · Cited by 71
“State-4 respiration and state-3 respiration are defined as oxygen consumption by isolated mitochondria in the absence and presence of ADP respectively on a particular substrate [64].”
BackgroundPhielix, E., Jeleník, T., Nowotny, P., Szendroedi, J., & Roden, M. (2013) · Diabetologia · doi:10.1007/s00125-013-3127-2 · Cited by 67
“The sample size of this RCTwas computed on values reported for mitochondrial function analysis as published previously [3].”
BackgroundMethodKenny, H. C., Rudwill, F., Breen, L., Salanova, M., Blottner, D., Heise, T., Heer, M., Blanc, S., & O’Gorman, D. J. (2017) · Diabetologia · doi:10.1007/s00125-017-4298-z · Cited by 64
Mitochondrial dynamics in skeletal muscle insulin resistance and type 2 diabetes
Fealy, C. E., Mulya, A., Axelrod, C. L., & Kirwan, J. P. (2018) · Translational Research · doi:10.1016/j.trsl.2018.07.011 · Cited by 63
Mitochondrial efficiency and insulin resistance
Crescenzo, R., Bianco, F., Mazzoli, A., Giacco, A., Liverini, G., & Iossa, S. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2014.00512 · Cited by 72
“…function was compromised by ∼45% in type 2 diabetic patients, although IMCL content was similar between the groups, suggesting that impaired mitochondrial function may be a more important determinant of diabetes than IMCL levels (Schrauwen-Hinderling et al., 2007; Phielix et al., 2008).”
BackgroundThe lifecycle of skeletal muscle mitochondria in obesity
Pileggi, C. A., Parmar, G., & Harper, M. (2021) · Obesity Reviews · doi:10.1111/obr.13164 · Cited by 61
Tsilingiris, D., Tzeravini, E., Koliaki, C. C., Dalamaga, Μ., & Kokkinos, A. D. (2021) · Current Obesity Reports · doi:10.1007/s13679-021-00434-0 · Cited by 63
“1 kg/m(2)), 12 first-degree relatives of patients with T2DM, and 16 healthy controls [93].”
BackgroundInfluentialVanweert, F., de Ligt, M., Hoeks, J., Hesselink, M. K. C., Schrauwen, P., & Phielix, E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa751 · Cited by 65
Self-citationBaker, P. R., Boyle, K. E., Koves, T. R., Ilkayeva, O., Muoio, D. M., Houmard, J. A., & Friedman, J. E. (2015) · Obesity · doi:10.1002/oby.21046 · Cited by 67
“Previous observations, by ourselves and others, show reduced lipid oxidation in skeletal muscle with obesity (6, 9, 20, 36), though these measures were made under fasted or in vitro conditions.”
Brouwers, B., Schrauwen-Hinderling, V. B., Jelenik, T., Gemmink, A., Havekes, B., Bruls, Y., Dahlmans, D., Roden, M., Hesselink, M. K. C., & Schrauwen, P. (2017) · Clinical Science · doi:10.1042/cs20170261 · Cited by 59
Self-citationExercising your fat (metabolism) into shape: a muscle-centred view
Gemmink, A., Schrauwen, P., & Hesselink, M. K. C. (2020) · Diabetologia · doi:10.1007/s00125-020-05170-z · Cited by 65
Self-citationWarren, B. E., Lou, P., Lucchinetti, E., Zhang, L., Clanachan, A. S., Affolter, A., Hersberger, M., Zaugg, M., & Lemieux, H. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00511.2013 · Cited by 61
Yang, C., Aye, C. C., Li, X., Díaz‐Ramos, A., Zorzano, A., & Mora, S. (2012) · Bioscience Reports · doi:10.1042/bsr20120034 · Cited by 65
Lee, H., Ha, T. Y., Jung, C. H., Nirmala, F. S., Park, S., Huh, Y. H., & Ahn, J. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12794 · Cited by 59
“Further, diabetes-prone individuals have decreased mitochondrial respiration.(32) Previously, a comparison of mice fed a HFD for 2 weeks with those fed a HFD for 12–16 weeks suggested that glucose intolerance by a long-term HFD resulted from inflammation in white adipose tissue and SKM.”
BackgroundMitochondrial dysfunction has divergent, cell type-dependent effects on insulin action
Martin, S. D., Morrison, S., Konstantopoulos, N., & McGee, S. L. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.02.001 · Cited by 58
“As reduced ADP-stimulated respiration has been observed in insulin resistant states [3,4,13], we used the ATP synthase inhibitor oligomycin to mimic aspects of this defect.”
MethodO’Connor, E., Kiely, C., O'Shea, D. B., Green, S., & Egaña, M. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00012.2012 · Cited by 63
Turner, N. A., & Robker, R. L. (2014) · Molecular Human Reproduction · doi:10.1093/molehr/gau042 · Cited by 61
“…https://academ ic.oup.com /m olehr/article-abstract/21/1/23/2964698 by guest on 16 M arch 2020 populations of insulin-resistant individuals (Petersen et al., 2003, 2004, 2005; Befroy et al., 2007; Schrauwen-Hinderling et al., 2007; Szendroedi et al., 2007; Phielix et al., 2008; Meex et al., 2010).”
BackgroundReguera, D. P., Díaz, S., Quesada, H., Fernández‐Iglesias, A., Mulero, M., Arola‐Arnal, A., Salvadó, M. J., Bladé, C., & Arola, L. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf200322x · Cited by 64
Vijgen, G. H. E. J., Bouvy, N. D., Hoeks, J., Wijers, S. L. J., Schrauwen, P., & Lichtenbelt, W. D. V. M. (2013) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2013.03.009 · Cited by 62
“Part of the muscle was directly used for the fresh preparation of permeabilized muscle fibers as described [3].”
InfluentialSelf-citationSafiedeen, Z., Rodríguez‐Gómez, I., Vergori, L., Soleti, R., Vaithilingam, D., Douma, I., Agouni, A., Leiber, D., Dubois, S. G., Simard, G., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6771 · Cited by 58
“Also, both basal and maximal adenosine diphosphate-stimulated respirations were decreased in type 2 patients (22, 28).”
Insulin resistance and mitochondrial function in skeletal muscle
Dela, F., & Helge, J. W. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.09.019 · Cited by 66
“It has also been suggested (Phielix et al., 2008; Ritov et al., 2010) that the mitochondria in insulin resistant people may have an intrinsic defect in specific components of the electron transport system, as opposed to a generally decreased mitochondrial content.”
BackgroundHansen, J., Timmers, S., Moonen-Kornips, E., Duez, H., Staels, B., Hesselink, M. K. C., & Schrauwen, P. (2016) · Scientific Reports · doi:10.1038/srep35047 · Cited by 55
“We cultured human primary myotubes from the following four groups: (1) young endurance trained athletes (TL) and (2) their age-matched young, lean sedentary controls (UL) and (3) healthy, obese subjects (OB) and (4) BMI- and age-matched type 2 diabetic patients (T2D) (Table 1).”
Self-citationFerrari, U., Then, C., Rottenkolber, M., Selte, C., Seissler, J., Conzade, R., Linkohr, B., Peters, A., Drey, M., & Thorand, B. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01523-7 · Cited by 52
Linking bioenergetic function of mitochondria to tissue-specific molecular fingerprints
Kappler, L., Hoene, M., Hu, C., von Toerne, C., Li, J., Bleher, D., Hoffmann, C., Böhm, A., Kollipara, L., Zischka, H., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00088.2019 · Cited by 57
Mitochondria and Antibiotics: For Good or for Evil?
Suarez-Rivero, J. M., Pastor‐Maldonado, C. J., Povea-Cabello, S., Álvarez-Córdoba, M., Villalón-García, I., Talaverón-Rey, M., Suárez-Carrillo, A., Munuera-Cabeza, M., & Sánchez-Alcázar, J. A. (2021) · Biomolecules · doi:10.3390/biom11071050 · Cited by 61
“Furthermore, a decrease in mitochondrial respiration was reported among the first-degree relatives of individuals suffering from T2DM, indicating that mitochondrial dysfunction precedes and most likely, triggers the onset of Type 2 diabetes [129].”
BackgroundWefers, J., Connell, N. J., Fealy, C. E., Andriessen, C., de Wit‐Verheggen, V. H. W., van Moorsel, D., Moonen‐Kornips, E., Jörgensen, J. A., Hesselink, M. K. C., Havekes, B., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101050 · Cited by 55
Self-citationImpairment of Mitochondrial Respiration in Metabolic Diseases: An Overview
Avram, V. F., Merce, A. P., Hâncu, I. M., Bătrîn, A. D., Kennedy, G., Rosca, M. G., & Muntean, D. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168852 · Cited by 54
“These changes in mitochondrial respiration are similar to thosse reported in skeletal muscle [90,93,96].”
BackgroundResultResveratrol and metabolic health in COPD: A proof-of-concept randomized controlled trial
Beijers, R. J. H. C. G., Gosker, H. R., Sanders, K. J. C., de Theije, C. C., KELDERS, M. C. J. M., Clarke, G. A., Cryan, J. F., van den Borst, B., & Schols, A. M. W. J. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.01.002 · Cited by 52
El‐Hafidi, M., Correa, F., & Zazueta, C. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165744 · Cited by 56
Mitochondrial Function and Insulin Resistance during Aging – A Mini-Review
Phielix, E., Szendroedi, J., & Roden, M. (2011) · Gerontology · doi:10.1159/000317691 · Cited by 47
“Furthermore, electron microscopic imaging identified different pools of myocellular mitochondria, of which the vast majority is located between the contractile filaments (intermyofibrillar mitochondria). These intermyofibrillar mitochondria are physically and possibly functionally distinct from mitochondria directly a…”
BackgroundMitochondrial function and diabetes: consequences for skeletal and cardiac muscle metabolism
Schrauwen-Hinderling, V. B., Kooi, M. E., & Schrauwen, P. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6291 · Cited by 47
“Using this methodology, basal as well as maximal ADP-stimulated respiration was reported to be decreased in type 2 diabetic patients (66, 82), and it persisted even after correction for mitochondrial density.”
Self-citationBuonvino, S., Arciero, I., & Melino, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158452 · Cited by 54
“Notably, since several recent studies highlight a link between insulin resistance and an altered electron transport chain [138,139] due to the ability of TST to influence mitochondrial respiration, there may be an implication of TST interaction with the iron-sulfur centers, correlated with the anti-diabetic effect exe…”
BackgroundErythropoietin Treatment Enhances Muscle Mitochondrial Capacity in Humans
Plenge, U., Belhage, B., Guadalupe‐Grau, A., Andersen, P. R., Lundby, C., Dela, F., Stride, N. O., Pott, F. C., Helge, J. W., & Boushel, R. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00050 · Cited by 47
“This has also been shown in pathological conditions such as type 2 diabetes (Mogensen et al., 2007; Phielix et al., 2008) and chronic obstructive lung disease (Naimi et al., 2011).”
Backgroundden Kamp, Y. J. M. O., Gemmink, A., de Ligt, M., Dautzenberg, B., Moonen‐Kornips, E., Jörgensen, J. A., Schaart, G., ESTERLINE, R. L., Pava, D., Hoeks, J., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101620 · Cited by 50
“Muscle biopsy On day 3 of the end-of-treatment visit, a percutaneous muscle biopsy was obtained from the vastus lateralis muscle in the fasted state before the start of a hyperinsulinemic euglycemic clamp and as described previously [31], under local anaesthesia (1% lidocaine), as described by Bergström et al.”
MethodInfluentialSelf-citationPaglialunga, S., van Bree, B., Bosma, M., Valdecantos, M. P., Amengual-Cladera, E., Jörgensen, J. A., van Beurden, D., den Hartog, G. J. M., Ouwens, D. M., Briedé, J. J., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2626-x · Cited by 50
Self-citationRemor, A. P., Matos, F., Ghisoni, K., da Silva, T. L., Eidt, G., Burigo, M. O., Bem, A. F. D., Silveira, P. C. L., de León, A., Sanchez, M. C., et al. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.06.017 · Cited by 53
“These results are in agreement with those from Phielix and coworkers, demonstrating reduced mitochondrial respiratory capacity (31%) in muscle fibers from diabetic individuals [67].”
Takahashi, T., Yamamoto, M., Amikura, K., Kato, K., Serizawa, T., Serizawa, K., Akazawa, D., Aoki, T., Kawai, K., Ogasawara, E., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.220673 · Cited by 44
“with type II diabetes compared with those of healthy individuals (Kelley et al., 2008; Phielix et al., 2008; Ritov et al., 2010).”
BackgroundChursa, U., Nuñez‐Durán, E., Cansby, E., Amrutkar, M., Sütt, S., Ståhlman, M., Olsson, B., Borén, J., Johansson, M. E., Bäckhed, F., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-4171-5 · Cited by 50
Kong, L., Zhao, H., Fan, J., Wang, Q., Li, J., Bai, J., & Mao, J. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-041578 · Cited by 46
Rabøl, R., Boushel, R., Almdal, T., Hansen, C. N., Ploug, T., Haugaard, S. B., Prats, C., Madsbad, S., & Dela, F. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01237.x · Cited by 44
Deane, C. S., Willis, C. R. G., Phillips, B. E., Atherton, P. J., Harries, L. W., Ames, R. M., Szewczyk, N. J., & Etheridge, T. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12706 · Cited by 45
Sinclair, A. J., Pennells, D., & Abdelhafiz, A. H. (2022) · Aging Clinical and Experimental Research · doi:10.1007/s40520-022-02142-8 · Cited by 48
Role of lipid-derived mediators in skeletal muscle insulin resistance
Taube, A., Eckardt, K., & Eckel, J. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00241.2009 · Cited by 40
Hoeks, J., de Wilde, J., Hulshof, M. F. M., van den Berg, S. A. A., Schaart, G., van Dijk, K. W., Smit, E., & Mariman, E. C. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027274 · Cited by 43
“Insulin resistance and type 2 diabetes are associated with impaired skeletal muscle mitochondrial function [1,2].”
BackgroundMetabolic Impact of Frailty Changes Diabetes Trajectory
Sinclair, A. J., & Abdelhafiz, A. H. (2023) · Metabolites · doi:10.3390/metabo13020295 · Cited by 46
Fritzen, A. M., Thøgersen, F. B., Thybo, K., Vissing, C. R., Krag, T. O. B., Ruiz‐Ruiz, C., Risom, L., Wibrand, F., Høeg, L. D., Kiens, B., et al. (2019) · Cells · doi:10.3390/cells8030237 · Cited by 41
Kristensen, J. M., Skov, V., Petersson, S. J., Ørtenblad, N., Wojtaszewski, J. F. P., Beck‐Nielsen, H., & Højlund, K. (2014) · Diabetologia · doi:10.1007/s00125-014-3187-y · Cited by 46
Ojuka, E. O., Andrew, B., Bezuidenhout, N., George, S., Maarman, G. J., Madlala, H. P., Mendham, A. E., & Osiki, P. O. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00475.2015 · Cited by 41
“For example, changes in ETS and OXPHOS capacities, which are observed after exercise training in muscle (16, 73), implicate changes in substrate oxidation and ATP synthesis machinery, respectively, whereas an alteration in LEAK state implicates a change in proton conductance (8, 22, 52).”
BackgroundSubmaximal ADP‐stimulated respiration is impaired in ZDF rats and recovered by resveratrol
Smith, B. K., Perry, C. G. R., Herbst, E. A. F., Ritchie, I. R., Beaudoin, M., Smith, J. C., Neufer, P. D., Wright, D. C., & Holloway, G. P. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.259226 · Cited by 37
“…surrounding the notion of mitochondrial dysfunction as a cause of insulin resistance (Kelley et al. 2002; Boushel et al. 2007; Mogensen et al. 2007; Phielix et al. 2008; de Feyter et al. 2008a,b; Holloszy, 2009; Holloway et al. 2010; Lenaers et al. 2010; Hoeks & Schrauwen, 2012), which may reflect…”
BackgroundMetabolic insights from extreme human insulin resistance phenotypes
Stears, A. J., O’Rahilly, S., Semple, R. K., & Savage, D. B. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.09.003 · Cited by 44
Mitochondrial phosphoproteomics of mammalian tissues
Kruse, R., & Højlund, K. (2016) · Mitochondrion · doi:10.1016/j.mito.2016.08.004 · Cited by 36
“In addition to the evidences of a reduced content of mitochondria, we and others have shown impaired mitochondrial respiration in skeletal muscle of patients with T2D and high-risk individuals, suggesting that intrinsic defects in the functional capacity of mitochondria contribute to mitochondrial dysfunction [109, 11…”
BackgroundBilet, L., Phielix, E., van de Weijer, T., Gemmink, A., Bosma, M., Moonen-Kornips, E., Jorgensen, J. A., Schaart, G., Zhang, D., Meijer, K., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05128-1 · Cited by 36
Self-citationSkeletal muscle respiratory capacity is enhanced in rats consuming an obesogenic Western diet
Stephenson, E. J., CAMERA, D. M., Jenkins, T. A., Kosari, S., Lee, J. S., Hawley, J. A., & Stepto, N. K. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00590.2011 · Cited by 42
Hoeks, J., Arany, Z., Phielix, E., Moonen‐Kornips, E., Hesselink, M. K. C., & Schrauwen, P. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22812 · Cited by 36
“…2 diabetes, COPD and aging is possibly caused by elevated oxidative stress (Houstis et al., 2006; Bonnard et al., 2008; Figueiredo et al., 2008; Puente-Maestu et al., 2009) and since overexpression of PGC-1a has been shown to alleviate oxidative stress (Kong et al., 2010), the secondary aim of…”
BackgroundSelf-citationSamocha‐Bonet, D., Heilbronn, L. K., Lichtenberg, D. A., & Campbell, L. V. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.09.008 · Cited by 38
de Goede, P., Wüst, R. C. I., Schomakers, B. V., Denis, S. W., Vaz, F. M., Pras‐Raves, M. L., van Weeghel, M., Yi, C., Kalsbeek, A., & Houtkooper, R. H. (2022) · The FASEB Journal · doi:10.1096/fj.202100707r · Cited by 42
The role of mitochondria in the pathophysiology and treatment of common metabolic diseases in humans
Georgiev, A., Granata, C., & Roden, M. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00035.2022 · Cited by 38
Intact Primary Mitochondrial Function in Myotubes Established from Women with PCOS
Eriksen, M. B., Minet, A. D., Glintborg, D., & Gaster, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0278 · Cited by 35
“dysfunction, in particular the respiratory capacity, in T2D is debated (6, 7).”
BackgroundSparks, L. M., Gemmink, A., Phielix, E., Bosma, M., Schaart, G., Moonen-Kornips, E., Jörgensen, J. A., Nascimento, E. B. M., Hesselink, M. K. C., Schrauwen, P., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-3885-8 · Cited by 34
“Plasma glucose and insulin concentrations and isotopic enrichment of plasma glucose were determined as previously described [19].”
MethodSelf-citationLayec, G., Gifford, J. R., Trinity, J. D., Hart, C. R., Garten, R. S., Park, S., Fur, Y. L., Jeong, E. K., & Richardson, R. S. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00028.2016 · Cited by 38
“In addition to the consistent lack of a cytochrome c response during the in vitro experiments, the maximal coupled respiration with convergent electron flux through CI CII (26–70 M·s (1)·mg (1)) was also within the span of values previously reported in the literature [ 27 M·s (1)·mg 1 (49), 30 – 80 M·s (1)·mg 1 (13),…”
ResultPino, M. F., Stephens, N. A., Eroshkin, A. M., Yi, F., Hodges, A. P., Cornnell, H. H., Pratley, R. E., Smith, S. R., Wang, M., Han, X., et al. (2019) · Physiological Genomics · doi:10.1152/physiolgenomics.00014.2019 · Cited by 36
Hong, J. H., Kim, B.-W., Choo, H. J., Park, J.-J., Yi, J.-S., Yu, D., Lee, H., Yoon, G.-S., Lee, J., & Ko, Y. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.560078 · Cited by 40
Kitzmann, M., Lantier, L., Hébrard, S., Mercier, J. G., Foretz, M., & Aguer, C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.007 · Cited by 34
“Numerous studies have shown a mitochondrial dysfunction in skeletal muscle of T2D patients [6-8] as well as in muscle from persons at risk for developing T2D [9, 10].”
BackgroundOxidative capacity varies along the length of healthy human tibialis anterior
Boss, A., Heskamp, L., Breukels, V., Bains, L. J., van Uden, M. J., & Heerschap, A. (2018) · The Journal of Physiology · doi:10.1113/jp275009 · Cited by 32
“It was shown to be higher in trained vs. untrained (Takahashi et al. 1995; Larsen et al. 2009), young vs. older (Fleischman et al. 2010), and in healthy subjects vs. patients with type II diabetes (Phielix et al. 2008; Bajpeyi et al. 2011).”
BackgroundSeifert, E. L., Fiehn, O., Bezaire, V., Bickel, D. R., Wohlgemuth, G., Adams, S. H., & Harper, M.-E. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009834 · Cited by 30
“the fasted state [9,10], as well as decreased subsarcolemmal mitochondrial content [11], decreased expression of oxidative phosphorylation genes [12,13], and decreased maximal NADHlinked phosphorylating respiration in isolated mitochondria [14,15].”
BackgroundLewis, M. T., Kasper, J. D., Bazil, J. N., Frisbee, J. C., & Wiseman, R. W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215271 · Cited by 37
Motor nerve decline does not underlie muscle weakness in type 2 Diabetic neuropathy
IJzerman, T. H., Schaper, N. C., Melai, T., Blijham, P. J., Meijer, K., Willems, P. J. B., & Savelberg, H. H. C. M. (2011) · Muscle & Nerve · doi:10.1002/mus.22039 · Cited by 33
“Phielix et al.15 showed that in vivo mitochondrial dysfunction in DM2 patients was accompanied by lower adenosine diphosphate (ADP)-driven mitochondrial respiration.”
BackgroundJardon, K. M. C., Goossens, G. H., Most, J., Galazzo, G., Venema, K., Penders, J., & Blaak, E. E. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2392875 · Cited by 34
Remie, C. M. E., Janssens, G. E., Bilet, L., van Weeghel, M., Duvivier, B. M. F. M., de Wit‐Verheggen, V. H. W., Connell, N. J., Jörgensen, J. A., Schomakers, B. V., Schrauwen‐Hinderling, V. B., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05558-5 · Cited by 33
Self-citationDahlmans, D., Houzelle, A., Andreux, P. A., Jörgensen, J. A., Wang, X., Windt, L. J. D., Schrauwen, P., Auwerx, J. H., & Hoeks, J. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.08.007 · Cited by 29
“miRNA-320a has been linked to T2DM in multiple studies [43], a disease repeatedly associated impaired mitochondrial function [6,44,45].”
BackgroundSelf-citationTrewin, A. J., Levinger, I., Parker, L., Shaw, C. S., Serpiello, F. R., Anderson, M. J., McConell, G. K., Hare, D. L., & Stepto, N. K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188421 · Cited by 32
“Interestingly, in our obese, older and sedentary subjects, there was no increase of J O 2 in response to insulin, which appears to be consistent with what has been previously demonstrated in patients with type-2 diabetes when compared with young, healthy individuals [26, 60, 61].”
Haspula, D., Vallejos, A. K., Moore, T. M., Tomar, N., Dash, R. K., & Hoffmann, B. R. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00558 · Cited by 31
“Although mitochondrial respiration, which serves as a direct assessment of mitochondrial functions, was reported by others to be diminished under diabetic conditions (Mogensen et al., 2007; Phielix et al., 2008), our data suggests a minimum impact of diabetic states and/or hyperglycemic states on it in RCMVECs.”
BackgroundThe effects of acute BPA exposure on skeletal muscle mitochondrial function and glucose metabolism
Ahmed, F., Chehadé, L., Garneau, L., Caron, A., & Aguer, C. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110580 · Cited by 30
Meex, R. C. R., Phielix, E., Moonen‐Kornips, E., Schrauwen, P., & Hesselink, M. K. C. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1816 · Cited by 30
“Detailed procedures on muscle fiber handling and respirometry measurements are previously described (25).”
BackgroundSelf-citationLim, E. L., Hollingsworth, K. G., Smith, F. E., Thelwall, P. E., & Taylor, R. (2011) · Clinical Science · doi:10.1042/cs20100611 · Cited by 31
Mitochondria as Potential Targets in Antidiabetic Therapy
Moreira, P. I., & Oliveira, C. R. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_14 · Cited by 32
“These later data have been confirmed, comparing overweight diabetic with nondiabetic subjects where in vivo skeletal muscle phosphocreatine recovery half-life after exercise is blunted in the diabetic subjects (Phielix et al. 2008; Schrauwen-Hinderling et al. 2007).”
ResultLenaers, E., Feyter, H. M. D., Hoeks, J., Schrauwen, P., Schaart, G., Nabben, M., Nicolay, K., Prompers, J. J., & Hesselink, M. K. C. (2009) · Obesity · doi:10.1038/oby.2009.372 · Cited by 28
“Recently, using a combined in vivo and ex vivo approach, we extended these findings in first-degree relatives with data indicating declined intrinsic mitochondrial function (12).”
BackgroundResultSelf-citationKunz, H., Dasari, S., & Lanza, I. R. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00083.2019 · Cited by 28
“As discussed in our previous work, although individuals with insulin resistance or type 2 diabetes exhibit mitochondrial dysfunction (40, 41) and short-term high-fat feeding can impair mitochondrial gene expression and function (20, 47), a growing body of literature challenges the role of mitochondrial dysfunction in…”
BackgroundHernández‐Álvarez, M. I., Chiellini, C., Manco, M., Naón, D., Liesa, M., Palacín, M., Mingrone, G., & Zorzano, A. (2009) · Diabetologia · doi:10.1007/s00125-009-1403-y · Cited by 30
“Muscle mitochondria from patients with type 2 diabetes show reduced size, reduced activity of the electron transport chain and reduced ADP-stimulated and maximal mitochondrial respiratory capacity [1, 36 , 37].”
BackgroundMitochondrial function in metabolic health: A genetic and environmental tug of war
Stephenson, E. J., & Hawley, J. A. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.12.004 · Cited by 32
Mitochondrial DNA copy number and diabetes: the Atherosclerosis Risk in Communities (ARIC) study
DeBarmore, B. M., Longchamps, R. J., Zhang, Y., Kalyani, R. R., Güallar, E., Arking, D. E., Selvin, E., & Young, J. H. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001204 · Cited by 28
SIRT3 as a Regulator of Non-alcoholic Fatty Liver Disease
Cho, E.-H. (2014) · Journal of Lifestyle Medicine · doi:10.15280/jlm.2014.4.2.80 · Cited by 28
“tion at the level of both electron-transport chain capacity and the oxidative phosphorylation system is implicated as the etiology of type 2 diabetes [25].”
BackgroundJakovljevic, N. K., Pavlović, K., Zujovic, T., Kravic‐Stevovic, T., Jotić, A., Marković, I., & Lalic, N. M. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.10.001 · Cited by 29
Harmsen, J., Kotte, M., Habets, I., Bosschee, F., Frenken, K. G., Jörgensen, J. A., de Kam, S. S., Moonen‐Kornips, E., Cissen, J., Doligkeit, D., et al. (2023) · The Journal of Physiology · doi:10.1113/jp285523 · Cited by 27
Self-citationSkeletal muscle mitochondrial energetics in obesity and type 2 diabetes mellitus: Endocrine aspects
Aguer, C., & Harper, M. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.06.001 · Cited by 31
Gavin, T. P., Ernst, J. M., Kwak, H., Caudill, S. E., Reed, M. A., Garner, R. T., Nie, Y., Weiss, J. A., Pories, W. J., Dar, M. S., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01727 · Cited by 25
ACE2 and energy metabolism: the connection between COVID-19 and chronic metabolic disorders.
Cao, X., Song, L.-N., & Yang, J.-K. (2021) · Clinical science · doi:10.1042/cs20200752 · Cited by 20
Mitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging-Related Diseases
Kong, B. S., Lee, C. D., & Cho, Y. M. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0333 · Cited by 27
Skeletal Muscle Phosphodiester Content Relates to Body Mass and Glycemic Control
Szendroedi, J., Schmid, A. I., Chmelík, M., Krššák, M., Nowotny, P., Prikoszovich, T., Kautzky‐Willer, A., Wolzt, M., Waldhäusl, W. K., & Roden, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021846 · Cited by 26
“Reduced mitochondrial oxidative capacity, activity and/ or content have been related to aging, intramyocelluar lipid content (IMCL) and muscular insulin resistance [1,2,3,4].”
BackgroundRole of Skeletal Muscle Mitochondrial Density on Exercise‐Stimulated Lipid Oxidation
Galgani, J. E., Johannsen, N. M., Bajpeyi, S., Costford, S. R., Zhang, Z., Gupta, A., & Ravussin, É. (2011) · Obesity · doi:10.1038/oby.2011.166 · Cited by 29
Insulin Increases Phosphorylation of Mitochondrial Proteins in Human Skeletal Musclein Vivo
Zhao, X., Bak, S. Y., Pedersen, A. J. T., Jensen, O. N., & Højlund, K. (2014) · Journal of Proteome Research · doi:10.1021/pr401163t · Cited by 25
Lund, M. T., Larsen, S., Hansen, M. V., Courraud, J., Floyd, A. K., Støckel, M., Helge, J. W., & Dela, F. (2018) · Acta Physiologica · doi:10.1111/apha.13032 · Cited by 24
“cellular energy imbalance.(1-7) However, a body of convincing evidence to support the proposed relationship between insulin resistance and mitochondrial respiratory function is lacking in the published literature.”
BackgroundAbdelhafiz, A. H., & SINCLAIR, A. J. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108144 · Cited by 23
Can resveratrol help to maintain metabolic health?
Schrauwen, P., & Timmers, S. (2014) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113003856 · Cited by 26
“In a subset of patients, we also confirmed the reduced intrinsic mitochondrial capacity in T2DM patients, which we reported earlier((20)), and showed that mitochondrial respiration in permeabilised muscle fibres was significantly improved and restored to control levels upon the 12-week training programme.”
Self-citationZoppi, C. C., Silveira, L. R., de Oliveira, C. A. M., Boschero, A. C., Curi, R., & Carneiro, E. M. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509993060 · Cited by 25
“In addition, reduced ADP phosphorylation in mitochondria from type 2 diabetic patients might result from reduced TAC and electron transport chain flux((116)).”
Background
Metadata
- Authors
- Phielix, E., Schrauwen-Hinderling, V. B., Mensink, M., Lenaers, E., Meex, R., Hoeks, J., Kooi, M. E., Moonen-Kornips, E., Sels, J.-P., Hesselink, M. K. C., & Schrauwen, P.
- Affiliations
- Department of Human Biology, Maastricht University, Maastricht, the Netherlands
- Maastricht University (NL)
- Maastricht University Medical Centre (NL)
- Corresponding author
- Schrauwen, Patrick
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-11-01
- Volume
- 57
- Issue
- 11
- Pages
- 2943-2949
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2570390
- OpenAlex
- W2112906476
- Cited by
- 359
- References
- 31
- Citations by year
- 2026: 5 · 2025: 14 · 2024: 13 · 2023: 26 · 2022: 28 · 2021: 26 · 2020: 20 · 2019: 17 · 2018: 14 · 2017: 12 · 2016: 28 · 2015: 13 · 2014: 17 · 2013: 25 · 2012: 29
- FWCI
- 9.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by-nc-nd)
- TU/e Research Portal (publishedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- TU/e Research Portal (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (016.066.359)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- type 2 diabetes, mitochondrial dysfunction, ADP-stimulated respiration, skeletal muscle, first-degree relatives, insulin sensitivity, insulin-stimulated glucose disposal, phosphocreatine recovery, electron transport chain, mitochondrial phosphorylation, F1-ATPase
- MeSH terms
- Adenosine Diphosphate, Diabetes Mellitus, Type 2, Glucose, Humans, Insulin, Male, Middle Aged, Mitochondria, Muscle, Cell Respiration, Carbohydrate Metabolism, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.